Trial NCT05835011

View at ClinicalTrials.gov 
Org. Study IDs: ASTX727-10
Secondary IDs: 2022-501548-14

Last trial update was posted on 2023-09-06

MeSH Interventions

Decitabine Magrolimab

MeSH Conditions

Myelodysplastic Syndromes Preleukemia Syndrome

Other Conditions


Stopping Reasons

Termination due to discontinuation of magrolimab development in MDS.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID